Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against difficult-to-treat targets in cancer and autoimmune diseases, and Cancer Research UK, the world’s leading cancer charity, today announced that the first patient has been treated in ...
Hummingbird Bioscience, an innovative clinical-stage biotechnology company focused on developing precision therapies against difficult-to-treat targets, today announced a Trials in Progress poster presentation highlighting the Phase 1 clinical trial design for HMBD-002. HMBD-002 is a unique antibody against VISTA, developed ...